US4032526A
(en)
|
1975-10-02 |
1977-06-28 |
American Cyanamid Company |
1,2-dimethyl-3 or 5-piperazinyl-pyrazolium salts
|
US4426382A
(en)
|
1980-02-13 |
1984-01-17 |
Sankyo Company Limited |
4-Amino-6,7-dimethoxy-2-piperazinylquinazoline derivatives, their preparation and use
|
DE3517617A1
(de)
|
1985-05-15 |
1986-11-20 |
Lentia GmbH Chem. u. pharm. Erzeugnisse - Industriebedarf, 8000 München |
Neue pyridaziniumverbindungen, verfahren zu deren herstellung und diese enthaltende fungizide und algizide mittel
|
ES8802151A1
(es)
|
1985-07-31 |
1988-04-01 |
Janssen Pharmaceutica Nv |
Un procedimiento para la preparacion de nuevos piridazinaminas.
|
JPS61165445A
(ja)
|
1986-01-08 |
1986-07-26 |
株式会社巴組鐵工所 |
振動を減少しうる床構造
|
US5096916A
(en)
|
1990-05-07 |
1992-03-17 |
Aegis Technology, Inc. |
Treatment of chronic obstructive pulmonary disease (copd) by inhalation of an imidazoline
|
EP0665833B1
(en)
|
1992-10-23 |
1999-07-14 |
MERCK SHARP & DOHME LTD. |
Dopamine receptor subtype ligands
|
JP3166376B2
(ja)
|
1993-02-03 |
2001-05-14 |
松下電器産業株式会社 |
熱利用装置
|
US5629235A
(en)
|
1995-07-05 |
1997-05-13 |
Winbond Electronics Corporation |
Method for forming damage-free buried contact
|
TW531537B
(en)
|
1995-12-27 |
2003-05-11 |
Janssen Pharmaceutica Nv |
1-(1,2-disubstituted piperidinyl)-4-substituted piperidine derivatives
|
US5629325A
(en)
|
1996-06-06 |
1997-05-13 |
Abbott Laboratories |
3-pyridyloxymethyl heterocyclic ether compounds useful in controlling chemical synaptic transmission
|
US6437138B1
(en)
|
1996-06-06 |
2002-08-20 |
Abbott Laboratories |
3-pyridyloxymethyl heterocyclic ether compounds useful in controlling chemical synaptic transmission
|
US6979686B1
(en)
|
2001-12-07 |
2005-12-27 |
Pharmacia Corporation |
Substituted pyrazoles as p38 kinase inhibitors
|
US6514977B1
(en)
|
1997-05-22 |
2003-02-04 |
G.D. Searle & Company |
Substituted pyrazoles as p38 kinase inhibitors
|
SK285198B6
(sk)
|
1997-10-27 |
2006-08-03 |
Neurosearch A/S |
Homopiperazínový derivát, farmaceutická kompozícia obsahujúca tento derivát a jeho použitie
|
US6143892A
(en)
|
1998-11-20 |
2000-11-07 |
G. D. Searle & Co. |
Process for making 5-substituted pyrazoles
|
US6248755B1
(en)
|
1999-04-06 |
2001-06-19 |
Merck & Co., Inc. |
Pyrrolidine modulators of chemokine receptor activity
|
HUP0202867A3
(en)
|
1999-05-04 |
2004-01-28 |
Schering Corp |
Piperazine derivatives useful as ccr5 antagonists and pharmaceutical compositions containing them
|
US20020045613A1
(en)
|
2000-04-27 |
2002-04-18 |
Heinz Pauls |
1-aroyl-piperidinyl benzamidines
|
CA2409827C
(en)
|
2000-05-22 |
2010-06-01 |
Aventis Pharmaceuticals Products Inc. |
Arylmethylamine derivatives for use as tryptase inhibitors
|
AU2002363236A1
(en)
|
2001-10-30 |
2003-05-12 |
Millennium Pharmaceuticals, Inc. |
Compounds, pharmaceutical compositions and methods of use therefor
|
US6806279B2
(en)
|
2001-12-17 |
2004-10-19 |
Sunesis Pharmaceuticals, Inc. |
Small-molecule inhibitors of interleukin-2
|
JP4607458B2
(ja)
|
2002-02-05 |
2011-01-05 |
ハイ・ポイント・ファーマスーティカルズ、エルエルシー |
新規なアリールおよびへテロアリールピペラジン
|
JP2003240776A
(ja)
|
2002-02-13 |
2003-08-27 |
Horiba Ltd |
クロマトグラフリーダを用いる測定方法およびそれに用いる試験片ホルダ並びにクロマトグラフリーダを用いる検査/測定装置
|
HUP0200849A2
(hu)
|
2002-03-06 |
2004-08-30 |
Sanofi-Synthelabo |
N-aminoacetil-2-ciano-pirrolidin-származékok, e vegyületeket tartalmazó gyógyszerkészítmények és eljárás előállításukra
|
US20030195192A1
(en)
|
2002-04-05 |
2003-10-16 |
Fortuna Haviv |
Nicotinamides having antiangiogenic activity
|
CN101450934B
(zh)
|
2002-03-13 |
2012-10-10 |
詹森药业有限公司 |
用作组蛋白去乙酰酶抑制剂的磺酰基衍生物
|
US20040014744A1
(en)
|
2002-04-05 |
2004-01-22 |
Fortuna Haviv |
Substituted pyridines having antiangiogenic activity
|
CA2483253A1
(en)
|
2002-04-24 |
2003-11-06 |
Takeda Pharmaceutical Company Limited |
Use of compounds having ccr antagonism
|
WO2003092586A2
(en)
|
2002-04-29 |
2003-11-13 |
Merck & Co., Inc. |
Tetrahydropyranyl cyclopentyl tetrahydropyridopyridine modulators of chemokine receptor activity
|
JP2005538958A
(ja)
|
2002-06-05 |
2005-12-22 |
ファルマシア・コーポレーション |
p38キナーゼ阻害薬としてのピラゾール誘導体
|
WO2004024710A1
(en)
|
2002-09-13 |
2004-03-25 |
Glaxo Group Limited |
Urea compounds active as vanilloid receptor antagonists for the treatment of pain
|
GB0229618D0
(en)
|
2002-12-19 |
2003-01-22 |
Cancer Rec Tech Ltd |
Pyrazole compounds
|
US20040147561A1
(en)
|
2002-12-27 |
2004-07-29 |
Wenge Zhong |
Pyrid-2-one derivatives and methods of use
|
WO2004074438A2
(en)
|
2003-02-14 |
2004-09-02 |
Smithkline Beecham Corporation |
Ccr8 antagonists
|
NZ542680A
(en)
|
2003-03-12 |
2008-08-29 |
Kudos Pharm Ltd |
Phthalazinone derivatives
|
JP2006528939A
(ja)
|
2003-04-23 |
2006-12-28 |
グラクソ グループ リミテッド |
ピペラジン誘導体ならびに神経および精神疾患の治療のためのその使用
|
FR2854158B1
(fr)
|
2003-04-25 |
2006-11-17 |
Sanofi Synthelabo |
Derives de 2-acylamino-4-phenylethiazole, leur preparation et leur application en therapeutique
|
TW200514781A
(en)
|
2003-07-18 |
2005-05-01 |
Glaxo Group Ltd |
Novel compounds
|
KR20060054392A
(ko)
|
2003-07-29 |
2006-05-22 |
노보 노르디스크 에이/에스 |
피리다지닐-피페라진 및 히스타민 h3 수용체 리간드로서그들의 사용
|
KR20080052683A
(ko)
|
2003-12-18 |
2008-06-11 |
인사이트 코포레이션 |
케모킨 수용체의 조절제로서의3-사이클로알킬아미노피롤리딘 유도체
|
GB0403155D0
(en)
|
2004-02-12 |
2004-03-17 |
Vernalis Res Ltd |
Chemical compounds
|
EP1720545B1
(en)
|
2004-03-03 |
2014-10-29 |
ChemoCentryx, Inc. |
Bicyclic and bridged nitrogen heterocycles
|
PE20060285A1
(es)
|
2004-03-30 |
2006-05-08 |
Aventis Pharma Inc |
Piridonas sustituidas como inhibidores de pol(adp-ribosa)-polimerasa (parp)
|
WO2005097751A2
(en)
|
2004-03-31 |
2005-10-20 |
Janssen Pharmaceutica, N.V. |
Non-imidazole heterocyclic compounds as histamine h3-receptor ligands
|
CA2563699C
(en)
|
2004-04-23 |
2014-03-25 |
Exelixis, Inc. |
Kinase modulators and method of use
|
WO2006001958A2
(en)
|
2004-05-21 |
2006-01-05 |
Merck & Co., Inc. |
Amino cyclopentyl heterocyclic and carbocyclic modulators of chemokine receptor activity
|
GEP20105024B
(en)
|
2004-06-02 |
2010-06-25 |
Takeda Pharmaceuticals Co |
Fused heterocyclic compound
|
FR2871157A1
(fr)
|
2004-06-04 |
2005-12-09 |
Aventis Pharma Sa |
Produits biaryl aromatiques, compositions les contenant et utilisation
|
AU2005267289A1
(en)
|
2004-06-24 |
2006-02-02 |
Incyte Corporation |
N-substituted piperidines and their use as pharmaceuticals
|
MX2007000036A
(es)
|
2004-06-25 |
2007-05-18 |
Johnson & Johnson |
Antagonistas del receptor 2 de citocina quimioatrayente de sales cuaternarias.
|
MXPA06014673A
(es)
|
2004-06-28 |
2007-03-26 |
Incyte Corp |
3-aminociclopentanocarbozamidas como moduladores de receptores de quimioquinas.
|
CA2577191A1
(en)
|
2004-08-26 |
2006-03-02 |
Kudos Pharmaceuticals Limited |
4-heteroarylmethyl substituted phthalazinone derivatives
|
GB0420831D0
(en)
|
2004-09-17 |
2004-10-20 |
Glaxo Group Ltd |
Novel compounds
|
CN101083994A
(zh)
|
2004-09-20 |
2007-12-05 |
泽农医药公司 |
杂环衍生物及其用作硬脂酰CoA去饱和酶抑制剂的用途
|
GB0421525D0
(en)
|
2004-09-28 |
2004-10-27 |
Novartis Ag |
Inhibitors of protein kineses
|
WO2006038734A1
(en)
|
2004-10-08 |
2006-04-13 |
Astellas Pharma Inc. |
Pyridazinone derivatives cytokines inhibitors
|
AU2005302225B2
(en)
|
2004-11-02 |
2012-05-24 |
Centre National De La Recherche Scientifique |
Pyridazine compounds, compositions and methods
|
UY29219A1
(es)
|
2004-11-22 |
2006-04-28 |
Incyte Corp |
Sales de la n-(2- (((3r)-1-(trans-4-hidroxi-4-(6-metoxipiridin-3-il)-cilohexil) pirrolidin-3-il)amino)-2-oxoetil)-3- (trifluorometil) benzamida
|
DE102004061751A1
(de)
|
2004-12-22 |
2006-07-06 |
Bayer Healthcare Ag |
Cyanoguanidin-substituierte Pyrazoline
|
RU2408580C2
(ru)
|
2005-02-17 |
2011-01-10 |
Астеллас Фарма Инк. |
Пиридильное неароматическое азотсодержащее гетероцикло-1-карбоксилатное производное
|
EP2527337A1
(en)
|
2005-04-14 |
2012-11-28 |
Bristol-Myers Squibb Company |
Inhibitors of 11-beta hydroxysteroid dehydrogenase type I
|
CA2604920A1
(en)
|
2005-04-15 |
2006-10-26 |
Elan Pharmaceuticals, Inc. |
Novel compounds useful for bradykinin b1 receptor antagonism
|
TW200716594A
(en)
|
2005-04-18 |
2007-05-01 |
Neurogen Corp |
Substituted heteroaryl CB1 antagonists
|
MX2007014619A
(es)
|
2005-05-20 |
2009-02-13 |
Vertex Pharma |
Pirrolopiridinas de utilidad como inhibidores de proteina quinasa.
|
WO2007003604A2
(en)
|
2005-07-04 |
2007-01-11 |
Novo Nordisk A/S |
Hists1mine h3 receptor antagonists
|
CA2606004A1
(en)
|
2005-08-02 |
2007-02-08 |
Neurogen Corporation |
Dipiperazinyl ketones and related analogues
|
GB0517184D0
(en)
|
2005-08-22 |
2005-09-28 |
Glaxo Group Ltd |
Compounds
|
AR055203A1
(es)
|
2005-08-31 |
2007-08-08 |
Otsuka Pharma Co Ltd |
Derivados de benzotiofeno con propiedades antipsicoticas
|
TW200800999A
(en)
|
2005-09-06 |
2008-01-01 |
Astrazeneca Ab |
Novel compounds
|
CN101272685A
(zh)
|
2005-09-27 |
2008-09-24 |
Irm责任有限公司 |
包含二芳基胺的化合物和组合物以及它们作为c-kit受体调节剂的用途
|
JO2769B1
(en)
|
2005-10-26 |
2014-03-15 |
جانسين فارماسوتيكا ان. في |
Rapid decomposition of physiologically antagonistic agents of the 2-dopamine receptor
|
US8067457B2
(en)
|
2005-11-01 |
2011-11-29 |
Millennium Pharmaceuticals, Inc. |
Compounds useful as antagonists of CCR2
|
WO2007053495A2
(en)
|
2005-11-01 |
2007-05-10 |
Millennium Pharmaceuticals, Inc. |
Compounds useful as antagonists of ccr2
|
EP1948636A2
(en)
|
2005-11-14 |
2008-07-30 |
Irm Llc |
Compounds and compositions as lxr modulators
|
KR20080076962A
(ko)
|
2005-12-20 |
2008-08-20 |
노파르티스 아게 |
대사성 글루타메이트 수용체 조절제로서의 니코틴산 유도체
|
IL172838A
(en)
|
2005-12-27 |
2010-06-16 |
Joma Int As |
Methods for production of metal oxide nano particles with controlled properties and nano particles and preparations produced thereby
|
WO2007084868A2
(en)
|
2006-01-17 |
2007-07-26 |
Kalypsys, Inc. |
Treatment of disorders by activation of the unfolded protein response
|
JO2660B1
(en)
|
2006-01-20 |
2012-06-17 |
نوفارتيس ايه جي |
Pi-3 inhibitors and methods of use
|
NZ570847A
(en)
|
2006-02-28 |
2011-10-28 |
Helicon Therapeutics Inc |
Therapeutic compounds
|
EP2024353A2
(en)
|
2006-03-16 |
2009-02-18 |
Pfizer Products Inc. |
Pyrazole compounds
|
JP2009533435A
(ja)
|
2006-04-11 |
2009-09-17 |
メルク エンド カムパニー インコーポレーテッド |
ジアリール置換アルカン
|
US7807671B2
(en)
|
2006-04-25 |
2010-10-05 |
Bristol-Myers Squibb Company |
Diketo-piperazine and piperidine derivatives as antiviral agents
|
EP2015751A2
(en)
|
2006-04-28 |
2009-01-21 |
Northwestern University |
Salts of pyridazine compounds
|
CN101472912A
(zh)
|
2006-06-22 |
2009-07-01 |
比奥维特罗姆上市公司 |
作为mnk激酶抑制剂的吡啶和吡嗪衍生物
|
CA2657247A1
(en)
|
2006-07-28 |
2008-01-31 |
Boehringer Ingelheim International Gmbh |
Compounds which modulate the cb2 receptor
|
GB0617575D0
(en)
|
2006-09-06 |
2006-10-18 |
Syngenta Ltd |
Herbicidal compounds and compositions
|
WO2008039645A1
(en)
|
2006-09-25 |
2008-04-03 |
Boehringer Ingelheim International Gmbh |
Compounds which modulate the cb2 receptor
|
US8754107B2
(en)
|
2006-11-17 |
2014-06-17 |
Abbvie Inc. |
Aminopyrrolidines as chemokine receptor antagonists
|
NZ577348A
(en)
|
2006-12-28 |
2012-04-27 |
Abbott Lab |
Inhibitors of poly(adp-ribose)polymerase
|
US20100204230A1
(en)
|
2007-02-12 |
2010-08-12 |
Peter Blurton |
Piperazine derivatives for treatment of ad and related conditions
|
JP4785881B2
(ja)
|
2007-02-27 |
2011-10-05 |
大塚製薬株式会社 |
医薬
|
FR2915552B1
(fr)
|
2007-04-27 |
2009-11-06 |
Technip France |
Conduite tubulaire flexible pour le transport d'hydrocarbures gazeux.
|
EP2155689B1
(en)
|
2007-05-31 |
2015-07-08 |
Boehringer Ingelheim International GmbH |
Ccr2 receptor antagonists and uses thereof
|
WO2009003861A1
(en)
|
2007-07-02 |
2009-01-08 |
F. Hoffmann-La Roche Ag |
Imidazole derivatives as ccr2 receptor antagonists
|
US7977358B2
(en)
|
2007-07-26 |
2011-07-12 |
Hoffmann-La Roche Inc. |
Pyrazol derivatives
|
KR101171488B1
(ko)
|
2007-08-22 |
2012-08-07 |
아이알엠 엘엘씨 |
키나제 억제제로서의 2-헤테로아릴아미노-피리미딘 유도체
|
AU2008307158A1
(en)
|
2007-10-01 |
2009-04-09 |
F. Hoffmann-La Roche Ag |
N-heterocyclic biaryl carboxamides as CCR receptor antagonists
|
CN101820789A
(zh)
|
2007-10-12 |
2010-09-01 |
黄钟午 |
鞋带捆绑工具
|
WO2009067406A1
(en)
|
2007-11-20 |
2009-05-28 |
Janssen Pharmaceutica N.V. |
Substituted pyridyl amide compounds as modulators of the histamine h3 receptor
|
WO2009066084A1
(en)
|
2007-11-21 |
2009-05-28 |
F. Hoffmann-La Roche Ag |
2 -morpholinopyrimidines and their use as pi3 kinase inhibitors
|
EP2225223B1
(de)
|
2007-11-22 |
2017-01-11 |
Boehringer Ingelheim International GmbH |
Organische verbindungen
|
EP2062889A1
(de)
|
2007-11-22 |
2009-05-27 |
Boehringer Ingelheim Pharma GmbH & Co. KG |
Verbindungen
|
MX2010013109A
(es)
*
|
2008-06-18 |
2010-12-20 |
Hoffmann La Roche |
Nuevos derivados de heteroaril-carboxamida.
|
MX2011001349A
(es)
|
2008-08-04 |
2011-08-17 |
Chidi Inc |
Ciertos inhibidores de quinurenin-3-monooxigenasa, composiciones farmaceuticas y metodos para su uso.
|
GB0815369D0
(en)
|
2008-08-22 |
2008-10-01 |
Summit Corp Plc |
Compounds for treatment of duchenne muscular dystrophy
|
EP2331506B1
(de)
|
2008-09-02 |
2013-07-03 |
Boehringer Ingelheim International GmbH |
Neue benzamide, deren herstellung und deren verwendung als arzneimittel
|
BRPI0919172A2
(pt)
|
2008-09-25 |
2015-12-15 |
Boehringer Ingelheim Int |
compostos os quais modulam seletivamente o receptor de cb2
|
PL2379525T3
(pl)
*
|
2008-12-19 |
2016-01-29 |
Centrexion Therapeutics Corp |
Cykliczne pirymidyno-4-karboksamidy jako antagoniści receptora CCR2 do leczenia stanów zapalnych, astmy oraz COPD
|
AU2010215041A1
(en)
|
2009-02-23 |
2011-07-28 |
Merck Canada Inc. |
Heterocyclic derivatives as inhibitors of stearoyl-coenzyme A delta-9 desaturase
|
RS53555B1
(en)
*
|
2009-12-17 |
2015-02-27 |
Boehringer Ingelheim International Gmbh |
NEW CCR2 RECEPTOR ANTAGONISTS AND THEIR APPLICATIONS
|
JP5658272B2
(ja)
|
2009-12-17 |
2015-01-21 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
Ccr2の新規アンタゴニスト及びこれらの使用
|
WO2011109324A1
(en)
|
2010-03-05 |
2011-09-09 |
Boehringer Ingelheim International Gmbh |
Tetrazole compounds which selectively modulate the cb2 receptor
|
EP2569295B1
(en)
|
2010-05-12 |
2014-11-19 |
Boehringer Ingelheim International GmbH |
New ccr2 receptor antagonists, method for producing the same, and use thereof as medicaments
|
JP2013526507A
(ja)
|
2010-05-12 |
2013-06-24 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
新規ccr2受容体アンタゴニスト、その製造方法及び薬物としてのその使用
|
US8841313B2
(en)
|
2010-05-17 |
2014-09-23 |
Boehringer Ingelheim International Gmbh |
CCR2 antagonists and uses thereof
|
EP2576542B1
(en)
|
2010-05-25 |
2015-04-22 |
Boehringer Ingelheim International GmbH |
Cyclic amide derivatives of pyridazine-3-carboxylic acids and their use in the treatment of pulmonary, pain, immune related and cardiovascular diseases
|
WO2011151251A1
(en)
|
2010-06-01 |
2011-12-08 |
Boehringer Ingelheim International Gmbh |
New ccr2 antagonists
|
EP2721025B1
(en)
|
2011-06-16 |
2015-11-25 |
Boehringer Ingelheim International Gmbh |
New selective ccr2 antagonists
|
JP5786258B2
(ja)
|
2011-07-15 |
2015-09-30 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
新規かつ選択的なccr2拮抗薬
|
BR112017028492B1
(pt)
|
2015-07-02 |
2023-12-26 |
Centrexion Therapeutics Corporation |
Citrato de (4-((3r,4r)-3-metoxitetra-hidro-piran-4- ilamino)piperidin-1-il) (5- metil-6-(((2r, 6s)-6-(p-tolil) tetra-hidro-2h-piran-2-il)metilamino)pirimidin-4-il) metanona, seu uso e seu método de preparação, e composição farmacêutica
|